Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
With
Regeneron Pharmaceuticals
Age
20–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Japanese men and women aged 20 years or older,
Patients diagnosed as having Neovascular glaucoma (NVG) with neovascularization in the anterior segment (both iris and anterior chamber angle),
Patients with Intraocular pressure (IOP) higher than 25 mmHg in the study eye due to anterior segment (both iris and anterior chamber angle) neovascularization.
You may not be if
Patients with angle-closure due to conditions other than Neovascular glaucoma
Patients with a known or suspected ocular or peri-ocular infection,
Patients with severe intraocular inflammation in the study eye,
Women who are pregnant, suspected of being pregnant or lactating,
Patients with known allergy to aflibercept.
Clareo Health | Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients
